Biogen Pharmachem Industries Limited (BOM:531752)

BOM:531752 Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Revenue	-	-	-	-	-	24.74
Other Revenue	14.59	25.58	11.98	7.89	2.5	0.07
Revenue	14.59	25.58	11.98	7.89	2.5	24.81
Revenue Growth	-10.72%	113.58%	51.78%	215.26%	-89.91%	52.90%
Cost of Revenue	-	-	-	-	-	20.15
Gross Profit	14.59	25.58	11.98	7.89	2.5	4.66
Selling, General & Admin	2.42	2.83	1.68	0.84	1.75	0.54
Other Operating Expenses	13.83	13.19	13	3.67	2.72	1.08
Operating Expenses	16.25	16.01	14.68	4.51	4.46	1.62
Operating Income	-1.67	9.57	-2.7	3.38	-1.96	3.04
Other Non Operating Income (Expenses)	0	0	-	-	-	-
EBT Excluding Unusual Items	-1.67	9.57	-2.7	3.38	-1.96	3.04
Gain (Loss) on Sale of Investments	-	-	-	-	-	-3.12
Gain (Loss) on Sale of Assets	-	-	-	15.92	6.63	-
Pretax Income	-1.67	9.57	-2.7	19.31	4.67	-0.09
Income Tax Expense	0.97	0.97	0.23	-	0.11	-
Net Income	-2.64	8.6	-2.93	19.31	4.56	-0.09
Net Income to Common	-2.64	8.6	-2.93	19.31	4.56	-0.09
Net Income Growth	-	-	-	323.86%	-	-
Shares Outstanding (Basic)	-	999	761	761	761	761
Shares Outstanding (Diluted)	-	999	761	761	761	761
Shares Change	-	31.27%	-	-	-	-
EPS (Basic)	-	0.01	-0.00	0.03	0.01	-0.00
EPS (Diluted)	-	0.01	-0.00	0.03	0.01	-0.00
EPS Growth	-	-	-	323.91%	-	-

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	18.79%
Operating Margin	-11.43%	37.40%	-22.54%	42.87%	-78.19%	12.24%
Profit Margin	-18.09%	33.60%	-24.44%	244.67%	181.98%	-0.35%
EBIT	-1.67	9.57	-2.7	3.38	-1.96	3.04
EBIT Margin	-11.43%	37.40%	-22.54%	42.87%	-78.19%	12.24%
Effective Tax Rate	-	10.17%	-	-	2.42%	-
Revenue as Reported	14.59	25.58	11.98	23.82	9.13	24.81

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error